Palvella Therapeutics (PVLA) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.46% |
| Dec 31, 2025 | -14.56% |
| Sep 30, 2025 | -12.28% |
| Jun 30, 2025 | -13.59% |
| Mar 31, 2025 | -16.64% |
| Dec 31, 2024 | -16.86% |
| Sep 30, 2024 | -50.00% |
| Jun 30, 2024 | -45.53% |
| Mar 31, 2024 | -36.61% |
| Dec 31, 2023 | -58.42% |
| Sep 30, 2023 | -19.94% |
| Jun 30, 2023 | -9.42% |
| Mar 31, 2023 | -12.73% |
| Dec 31, 2022 | -12.20% |
| Sep 30, 2022 | -5.30% |
| Jun 30, 2022 | -4.40% |
| Mar 31, 2022 | 1.52% |
| Dec 31, 2021 | 2.80% |
| Sep 30, 2021 | 2.68% |
| Jun 30, 2021 | -1.46% |
| Mar 31, 2021 | -12.57% |
| Dec 31, 2020 | 0.36% |
| Sep 30, 2020 | 5.39% |
| Jun 30, 2020 | 3.59% |
| Mar 31, 2020 | 26.00% |
| Dec 31, 2019 | 59.06% |
| Sep 30, 2019 | 38.75% |
| Jun 30, 2019 | 41.22% |
| Mar 31, 2019 | 52.15% |
| Dec 31, 2018 | 60.87% |
| Sep 30, 2018 | 61.21% |
| Jun 30, 2018 | 123.68% |
| Mar 31, 2018 | 117.77% |
| Dec 31, 2017 | 68.13% |
| Sep 30, 2017 | 7,559.51% |
| Jun 30, 2017 | 2,018.88% |
| Mar 31, 2017 | 6,709.05% |
| Dec 31, 2016 | 68.90% |
| Jun 30, 2016 | 1,974.95% |